Finnish study finds revised dementia guidelines did not reduce psychotropic use

A recent register-based study examined the impact of Finland’s revised clinical guidelines for the treatment of dementia, published in 2017, on the trend of users of psychotropics in older people with dementia in 2009-2020.

89bio’s $125M offering; Another FDA hold for Kezar

Plus, news about Nip­pon Shinyaku, At­se­na, Or­na Ther­a­peu­tics, Ovid Ther­a­peu­tics, Gravi­ton Bio­science, Eu­prax­ia, En­tero Ther­a­peu­tics, Jour­ney Ther­a­peu­tics, Ther­a­vance Bio­phar­ma, Al­pha Cog­ni­tion and Tra­vere Ther­a­peu­tics: …

Read More »